首页> 外国专利> Method of inhibiting Clostridium difficile by administration of oritavancin

Method of inhibiting Clostridium difficile by administration of oritavancin

机译：奥利万星抑制艰难梭菌的方法

展开▼

页面导航

摘要

著录项

相似文献

摘要

Glycopeptide antibiotics, such as oritavancin, demonstrate significant activity against both a vegetative form of C. difficile and C. difficile spores. Methods for the treatment, prophylaxis and prevention of C. difficile infection and disease in animals, including humans, are described. 展开▼

机译：糖肽抗生素，例如奥利万星，显示出对两种营养形式的I C的显着活性。困难和 C。艰难的孢子。 I C的治疗，预防和预防方法。描述了包括人在内的动物的难治性感染和疾病。 展开▼

著录项

公开/公告号US9220749B2

专利类型

公开/公告日2015-12-29

原文格式PDF

申请/专利权人 THE MEDICINES COMPANY;
展开▼

申请/专利号US201314101645

发明设计人 MARK HARVEY WILCOX;SIMON BAINES;DARIO LEHOUX;THOMAS R. PARR;
展开▼

申请日2013-12-10

分类号A61K31/33;A61K39;A61K39/02;A61K39/08;A61K38/14;A01N43/90;

国家 US

入库时间 2022-08-21 14:29:03

相似文献

专利

外文文献

中文文献

1. 通过奥利万星给药抑制艰难梭菌的方法 [P] . 中国专利： CN102316885A . 2012-01-11

2. 发酵制备奥利万星中间体的方法 [P] . 中国专利： CN109811024B . 2021.08.06

3. METHOD OF INHIBITING CLOSTRIDIUM DIFFICILE BY ADMINISTRATION OF ORITAVANCIN [P] . 欧洲知识产权局专利： EP2195004B1 . 2015-04-01

机译：通过奥利万星的抑制剂抑制艰难梭菌的方法

4. Method to inhibit Clostridium difficile by administration of oritavancin [P] . ES2535928T3 . 2015-05-19

机译：奥利万星抑制难辨梭菌的方法

5. Method of inhibiting clostridium difficile by administration of oritavancin [P] . 美国专利： US8629100B2 . 2014-01-14

机译：奥利万星抑制难辨梭状芽胞杆菌的方法

1. Inpatient Proton Pump Inhibitor Administration and Hospital-Acquired Clostridium difficile Infection: Evidence and Possible Mechanism [J] . Wombwell Eric, Chittum Megan E., Leeser Kayla R. The American Journal of Medicine . 2018,第3期

2. Inpatient Proton Pump Inhibitor Administration and Hospital-Acquired Clostridium difficile Infection: Evidence and Possible Mechanism [J] . Wombwell Eric, Chittum Megan E., Leeser Kayla R. The American Journal of Medicine . 2018,第3期

3. Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea [J] . Journal of critical care . 2014,第4期

4. The Effect of Ciprofloxacin on the Proteome of a Hypervirulent NAP1 Clostridium difficile Measured Using iTRAQ and Label-free methods [C] . Patrick Chong, Tarah Lynch, Stuart McCorrister, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2012

5. Development of peptide inhibitors targeting Clostridium difficile toxins A/B and characterizing the regulatory role of a putative negative regulator TcdC in Clostridium difficile toxin gene expression. [D] . Abdeen, Sanofar J. 2013

6. Comparison of Nine Commercially Available Clostridium difficile Toxin Detection Assays a Real-Time PCR Assay for C. difficile tcdB and a Glutamate Dehydrogenase Detection Assay to Cytotoxin Testing and Cytotoxigenic Culture Methods [O] . Kerrie Eastwood, Patrick Else, André Charlett, 2009

7. Effectiveness of a short (4 day) course of oritavancin in the treatment of simulated Clostridium difficile infection using a human gut model [O] . C. H. Chilton, J. Freeman, G. S. Crowther, 2012

1. Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis [J] . Anca Trifan ,Carol Stanciu ,Irina Girleanu . 世界胃肠病学杂志：英文版 . 2017,第35期

2. Incidence of iClostridium difficile/i-associated diarrhea in patients using proton pump inhibitors: A Japanese study [J] . Takatoshi Kitazawa ,Yusuke Yoshino ,Ichiro Koga . 肠胃病学期刊（英文） . 2013,第5期

3. Clostridium difficile infection in the community:Are proton pump inhibitors to blame? [J] . Daniel E Freedberg ,Julian A Abrams . 世界胃肠病学杂志：英文版 . 2013,第40期

4. Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea [J] . Ji Won Kim ,Kook Lae Lee ,Ji Bong Jeong . 世界胃肠病学杂志：英文版 . 2010,第28期

5. Simplified purification method for Clostridium difficile toxin A [J] . Si-WuFu JingXue Ya-LiZhang Dian-YuanZhou . 世界胃肠病学杂志：英文版 . 2004,第18期

6. 非达霉素与万古霉素治疗艰难梭菌感染的有效性和安全性比较——系统评价和荟萃分析 [C] . ZHI-KANG YE ,叶志康 ,HUI-LIN TANG . 2013北京抗感染药理与合理用药年会 . 2013

7. 血液病患者产毒艰难梭菌定植和感染危险因素的前瞻性研究及临床分离艰难梭菌的耐药性分析 [A] . 王洁 . 2014